The Weekly Recap 3/7/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni raise over $403M, achieve clinical and regulatory milestones, appoint new executives, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21).

4C Medical Technologies

Raised $175M in Series D financing to advance the development of AltaValve System, its transcatheter mitral valve replacement (TMVR) device. The funding will support its ongoing pivotal trial, ATLAS, in the United States and Europe.

Aescape

Secured $83M in strategic funding to expand its AI-powered robotic massage technology. Founder & CEO Eric Litman will take the stage at LSI USA ‘25 for a Fireside Chat, “Wellness 3.0: Building and Scaling a Robotics Startup in a New Era of Well-Being,” to discuss Aescape’s journey, vision, and the future of technology-driven wellness.

Ajax Health

Formed FlowMod, a new platform in collaboration with KKR and Boston Scientific, to develop a novel system for treating heart failure. Led by Dr. Philippe Marco, FlowMod aims to accelerate the clinical validation and regulatory approval of this technology to address the 64 million people affected by heart failure worldwide.

Atmo Biosciences

Published pivotal clinical study results in Clinical Gastroenterology and Hepatology, validating its Atmo Gas Capsule for assessing common gastrointestinal motility disorders. The data will support a U.S. FDA 510(k) submission.

Capstan Medical

Completed the world’s first robotic-assisted transcatheter mitral valve replacements, demonstrating unprecedented catheter stability and precision. Following its $110M Series C funding, Capstan is advancing toward pivotal trials to expand access to minimally invasive heart valve interventions.

CorWave

Appointed Anne Reiser to its Board of Directors as the representative of the EIC Fund. Reiser’s leadership in heart failure therapies and medtech growth will help drive CorWave’s mission to bring its next-generation LVAD technology to patients.

Discure Technologies

Announced acceptance into the FDA’s TAP Program for its breakthrough device for treating degenerative disc disease. This designation will accelerate regulatory review and support clinical validation of its bioelectronic implant.

Endologix

Appointed Andrew Davis as Chief Commercial Officer to lead its global market expansion and commercial strategy. With over 25 years in vascular and cardiovascular device sales, Davis will drive revenue growth, customer engagement, and strategic business development.

Flosonics Medical

Secured $7.5M CAD in venture debt from RBCx to expand FloPatch, the first wireless wearable Doppler ultrasound for fluid management in critical care. The funding will accelerate adoption, helping hospitals optimize sepsis care, reduce complications, and improve patient outcomes.

Intuitive Ventures

Appointed Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor to expand its investment platform in minimally invasive care. With extensive experience in medtech investing and healthcare innovation, they will help scale Intuitive Ventures’ $250M portfolio.

Nanochon

Partnered with Virginia Tech’s Marion duPont Scott Equine Medical Center to conduct an equine study evaluating its cartilage regeneration implant. The study, funded by Virginia Catalyst, will generate key preclinical data ahead of first-in-human trials.

Nervonik

Raised $13M in Series A financing to advance its peripheral nerve stimulation system for chronic pain relief. The funding will support clinical trials and regulatory efforts, bringing its neuromodulation technology closer to commercialization.

Ossiform

Appointed LSI Alumni Monica Wellejus as Chief Commercial Officer to lead the global strategy for its 3D-printed bone implant solutions. With experience in musculoskeletal innovation and medtech strategy, Wellejus will oversee all commercial and go-to-market activities.

Osteoboost Health (Bone Health Technologies)

Shared that it was awarded its 6th U.S. patent for OsteoBoost, a wearable device designed to treat osteopenia and improve bone health. This strengthens the company’s intellectual property and supports its expansion in non-drug, non-invasive bone health solutions.

Pulnovo Medical

Closed nearly $100M in Series C financing to advance its pulmonary artery denervation (PADN) technology for pulmonary hypertension and heart failure. The funds will support clinical trials, regulatory approvals, and international expansion.

Qaelon Medical

Qaelon announced a non-exclusive data partnership with RevMedica to improve stapler performance and clinical outcomes in gastrointestinal surgery. By integrating RevMedica's advanced stapler technology with Qaelon's real-time leak detection and performance data, the collaboration aims to accelerate product development, assess tissue impact on staple line performance, and assist with regulatory approvals.

Sofinnova Partners

Raised €1.2B, bringing total AUM to over €4B, to fund biotech, medtech, and digital health innovation. The firm plans to back 50-60 new companies and leverage Sofinnova.ai to accelerate disruptive life sciences investments.

StarTric

Secured a €2.5M EIC Grant and up to €8.4M in equity financing to advance TriClover, a minimally invasive tricuspid valve repair system. The funding will accelerate clinical validation, bringing a breakthrough treatment for tricuspid regurgitation patients closer to market.

Vektor Medical

Closed an oversubscribed $25M Series A funding round to scale vMap, its AI-powered arrhythmia mapping technology. The investment will support commercialization efforts, additional clinical studies, and expansion into the European market.

Wellysis

Appointed Dominic P. Renda Jr. as Chief Commercial Officer to lead the global expansion of its AI-powered remote cardiac monitoring solutions. His experience in scaling digital health and medtech will drive strategic partnerships and commercialization efforts.

Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.